Drugs / LAS41004
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02180464 | Jun → Dec 2014 | psoriasis | Almirall, S.A. | Completed | No outcome recorded |
| Phase 2 | NCT01462643 | Aug → Sep 2011 | psoriasis | Almirall, S.A. | Completed | No outcome recorded |
| Phase 2 | NCT01360944 | May → Jun 2011 | psoriasis | Almirall, S.A. | Completed | No outcome recorded |
| Phase 2 | NCT01283698 | Jan → Mar 2011 | psoriasis | Almirall, S.A. | Completed | No outcome recorded |
| Phase 2 | NCT01119339 | Jul → Sep 2010 | psoriasis | Almirall, S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAS41004 | “Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis” NCT01283698 ↗ |
| Route | Topical | “once daily, topical, 100 microgram” NCT01360944 ↗ |